"You've got a general feeling a lot of good news is priced in to this market," Hogan said. "That holds with technology. The problem with momentum stocks, once they start heading in a direction they get there violently and that's what we're seeing today."
Earlier in the day, the Dow climbed to a record 21,790.13, while the S&P 500 reached a record 2,484.04, while the Nasdaq gained to a record 6,460.84
In the Dow, rallies in shares of Verizon and those of Merck, recently up 7.6 per cent and 3.3 per cent respectively, outweighed declines in shares of Apple and those of American Express, recently down 2.3 per cent and 2 per cent respectively.
In Europe, the Stoxx 600 Index finished the day with a decline of 0.1 per cent from the previous close. The UK's FTSE 100 Index slipped 0.1 per cent, while France's CAC 40 Index also fell 0.1 per cent, and Germany's DAX Index declined 0.8 per cent.
Shares of AstraZeneca plunged, ending the day 15.4 per cent lower in London for the largest percentage drop in the FTSE 100, on disappointing trial results for a cancer treatment.
Nestle shares closed 1 per cent weaker in Zurich after the world's No. 1 food company warned it expects full-year organic growth to come in at the lower end of expectations.
"Organic growth in the first half did not fully meet our expectations," Mark Schneider, Nestlé CEO, said in a statement. "While volume growth remains at the high end of our industry, pricing continues to be soft."
Full-year organic growth for 2017 will likely be in the lower half of the 2-per cent-to-4-per cent range, Nestle said. That would be the worst performance in two decades, according to Bloomberg and Reuters.
"Food companies will need to reinvent themselves, and a lot will have to change in the sector, especially in the developed markets like Japan, Europe and North America," Patrik Lang, head of equity research at Julius Baer Group, told Bloomberg. "That's what we're starting to see: Nestle wants to invest more in the health trend, Unilever is developing more and more into a company that commits to personal hygiene and Danone is searching for its own identity."
Meanwhile, Diageo shares rallied, closing 6 per cent higher in London, after the world's top distiller announced a 1.5-billion pound (US$2 billion) share buyback and upgraded its goal for profit-margin growth.
"Our productivity work is delivering ahead of expectations allowing us to reinvest in our brands, drive margin improvement and generate consistent strong cash flow," Ivan Menezes, chief executive, said in a statement.
Diageo said it raised its margin improvement objective to 175 basis points, up from a previous goal for 100 basis points, over the three years ending June 30, 2019.